RVX-208: A SMALL MOLECULE THAT INCREASES APOA-I, HDL-C, AND CHOLESTEROL EFFLUX

被引：1
|
作者：
Jahagirdar, R. [1 ]
Genest, J. [2 ]
Hansen, H. C. [1 ]
Nicholls, C. D. [1 ]
Attwell, S. [1 ]
McLure, K. G. [1 ]
Wagner, G. S. [1 ]
Johansson, J. [1 ]
Wong, N. C. [1 ]
机构：
[1] Resverlogix Corp, Pharmacol, Calgary, AB, Canada
[2] McGill Univ, Montreal, PQ, Canada
来源：
ATHEROSCLEROSIS SUPPLEMENTS | 2008年 / 9卷 / 01期
关键词：
D O I：
10.1016/S1567-5688(08)70007-2
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：2 / 2
页数：1
相关论文
共 50 条
  • [1] RVX-208 A SMALL MOLECULE INCREASES APOA-I, PREB-HDL, AND FUNCTIONALITY OF HDL IN HUMANS
    Gordon, A.
    Jahagirdar, R.
    Johansson, J.
    Chiacchia, F.
    Hansen, H.
    Wagner, G.
    Bailey, D.
    Krimbou, L.
    Genest, J., Jr.
    Wong, N.
    ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (02)
  • [2] RVX-208 an orally active small molecule increases ApoA-I, pre-beta-HDL, HDL functionality and inhibits markers of inflammation
    Wong, N. C. W.
    Gordon, A.
    Wagner, G. S.
    Attwell, S.
    Jahagirdar, R.
    Mclure, K.
    Chiacchia, F. S.
    Johhansson, J.
    Bailey, D.
    Genest, J.
    EUROPEAN HEART JOURNAL, 2009, 30 : 960 - 960
  • [3] RVX-208 INCREASES APOA-I, PRE-B-HDL, HDL FUNCTIONALITY AND INHIBITS MARKERS OF INFLAMMATION
    Gordon, A.
    Attwell, S.
    Jahagirdar, R.
    Wong, N.
    ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (02)
  • [4] RVX-208 GIVEN ORALLY RAISES PLASMA apoA-I AND HDL IN HUMAN CLINICAL TRIALS
    Gordon, A.
    Johansson, J.
    Wagner, G.
    Chiacchia, F.
    Wong, N.
    ATHEROSCLEROSIS SUPPLEMENTS, 2010, 11 (02) : 11 - 11
  • [5] RVX-208, an Inducer of ApoA-I in Humans, Is a BET Bromodomain Antagonist
    McLure, Kevin G.
    Gesner, Emily M.
    Tsujikawa, Laura
    Kharenko, Olesya A.
    Attwell, Sarah
    Campeau, Eric
    Wasiak, Sylwia
    Stein, Adam
    White, Andre
    Fontano, Eric
    Suto, Robert K.
    Wong, Norman C. W.
    Wagner, Gregory S.
    Hansen, Henrik C.
    Young, Peter R.
    PLOS ONE, 2013, 8 (12):
  • [6] RVX-208, a Small Molecule Increases Apolipoprotein A-I, Pre-beta HDL, and Mature HDL in Humans
    Gordon, Allan
    Johansson, Jan
    Chiacchia, Fabrizio
    Jahagirdar, Ravi
    Wagner, Gregory
    Bailey, Dana
    Hansen, Henrik
    Krimbou, Larbi
    Genest, Jacques, Jr.
    Wong, Norman C.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2009, 29 (07) : E66 - E66
  • [7] Effects of the ApoA-I Inducer RVX-208 on Glucose Metabolism in Individuals with Prediabetes
    Siebel, Andrew L.
    Formosa, Melissa F.
    Natoli, Alaina K.
    Reddyluthmoodoo, Medini
    Carey, Andrew L.
    Van Hall, Gerrit
    Otvos, Jim D.
    Rye, Kerryanne
    Johansson, Jan
    Gordon, Allan
    Wong, Norman
    Barter, Philip
    Duffy, Stephen J.
    Kingwell, Bronwyn A.
    DIABETES, 2015, 64 : A307 - A307
  • [8] Different association of HDL-C, apoA-I, and HDL-C/apoA-I with multiple outcomes in HFrEF patients
    Abudukeremu, Ayiguli
    Chen, Qiaofei
    Pan, Zhanpeng
    Liu, Xiao
    Huang, Tongsheng
    Jiang, Yuan
    Li, Hongwei
    Sun, Runlu
    Pan, Hong
    Wen, Kexin
    Wang, Yue
    Zheng, Minglong
    Su, Zizhuo
    Zhang, Yuling
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2025, 422
  • [9] RVX-208, an Orally Active Small Molecule, Raises ApoA-I Production and HDL Levels in Human Trials and Also Reduces Plaque Numbers in a Mouse Model of Atherosclerosis
    Jahagirdar, Ravi
    Gordon, Allan
    Azhar, Salman
    Zhang, Haiyan
    Johansson, Jan
    Wagner, Gregory S.
    Chiacchia, Fabrizio S.
    Wong, Norman C.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2010, 30 (11) : E193 - E193
  • [10] RVX-208: a small molecule given orally raises ApoA-I/HDL in human clinical trials and reduces plaque numbers in an ApoE null mouse model of atherosclerosis
    Wong, N.
    Jahagirdar, R.
    Gordon, A.
    Azhar, S.
    Zhang, H.
    Johansson, J.
    Wagner, G.
    Chiacchia, F.
    EUROPEAN HEART JOURNAL, 2010, 31 : 909 - 909
12345